Subretinal Injection for Gene Therapy Does Not Cause Clinically Significant Outer Nuclear Layer Thinning in Normal Primate Foveae
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Purpose: Despite ever-growing adoption of subretinal (SRi) and intravitreal injections (IVTi) in ocular gene therapy trials, concerns regarding possible deleterious effects of the SRi on the outer retina are yet to be addressed. SRi offers several advantages over IVTi, such as a better photoreceptor transduction efficiency and a limited off-target exposure. We assessed structural changes in the outer retina in nonhuman primates following either SRi or IVTi of a gene therapeutic or control solution and compared both techniques in a noninferiority analysis. Methods: In a toxicology study, 22 cynomolgus monkeys underwent single intraocular injections with rAAV2/8 or vehicle; 18 animals received SRi, 4 animals received IVTi. Outer nuclear layer (ONL) thickness change on optical coherence tomography was used for a noninferiority analysis. Preservation of the physiological foveal bulge was used as a secondary outcome measure. Results: The average ONL change from baseline after 2 weeks was -6.54 ± 5.16 (mean ± SD μm) and +1.50 ± 4.36 for SRi and IVTi groups accordingly. At 13 weeks, the SRi group maintained a difference of -6.54 ± 9.66 while IVTi group gained +1.00 ± 4.24. The ellipsoid zone line was transiently lost after SRi and completely recovered by 13 weeks in 77% of eyes. One SRi case resulted in subfoveal pigment accumulation and 39% ONL thinning. Conclusions: Despite limited ONL thinning following SRi, the observed effect was under the predefined clinical significance threshold. The SRi has proven not to be inferior to the IVTi in terms of ONL thickness loss and estimated loss of visual acuity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the difference was not clinically significant.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [90]
In the citing paper
“Ochacovski et al89 have shown that subretinal injection, in NHPs, can cause mild thinning of the outer layers of the fovea in comparison with an intravitreal injection of the same vector.89,90”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [90]
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796
A qualitative and quantitative analysis of the human fovea during development
Yuodelis, C., & Hendrickson, A. (1986) · Vision Research · doi:10.1016/0042-6989(86)90143-4 · Cited by 704 · cited 1×
“The bulge corresponds anatomically to the elongated outer segments of the foveolar cone photoreceptors.(11) Hence, it is not surprising that the foveal bulge has been significantly correlated with better VA in occult macular dystrophy, branch retinal vein occlusion, and retinal detachment repair.”
BackgroundJacobson, S. G. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.298 · Cited by 639 · cited 2×
“Concerns regarding SRi effect on the retina were raised by Jacobson et al.3 based largely on a single case of persistent outer nuclear layer (ONL) thinning after subretinal injection.”
BackgroundStructural Grading of Foveal Hypoplasia Using Spectral-Domain Optical Coherence Tomography
Thomas, M. G., Kumar, A., Mohammad, S., Proudlock, F. A., Engle, E. C., Andrews, C., Chan, W.-M., Thomas, S., & Gottlob, I. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.028 · Cited by 427
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C., McCague, S., Pierce, E. A., Chen, Y., Bennicelli, J. L., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002865 · Cited by 395
Apoptotic photoreceptor degeneration in experimental retinal detachment.
Cook, B. E., Lewis, G. P., Fisher, S. K., & Adler, R. (1995) · PubMed · Cited by 367
Foveal Microstructure and Visual Acuity after Retinal Detachment Repair
Wakabayashi, T., Oshima, Y., Fujimoto, H., Murakami, Y., Sakaguchi, H., Kusaka, S., & Tano, Y. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.001 · Cited by 296
Visual Acuity after Retinal Gene Therapy for Choroideremia
Edwards, T. L., Jolly, J. K., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Black, G. C., Webster, A. R., Lotery, A. J., Holder, G. E., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1509501 · Cited by 195
Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
Campochiaro, P. A., Lauer, A. K., Sohn, E. H., Mir, T. A., Naylor, S., Anderton, M. C., Kelleher, M., Harrop, R., Ellis, S., & Mitrophanous, K. A. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.117 · Cited by 186
Cited by
Clinical Perspective: Treating RPE65-Associated Retinal Dystrophy
Maguire, A. M., Bennett, J., Aleman, E. M., Leroy, B. P., & Aleman, T. S. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.029 · Cited by 184
Fischer, M. D., Michalakis, S., Wilhelm, B., Zobor, D., Muehlfriedel, R., Kohl, S., Weisschuh, N., Ochakovski, G. A., Klein, R., Schoen, C., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.1032 · Cited by 177
Self-citationAAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye
Reichel, F. F., Dauletbekov, D. L., Klein, R., Peters, T., Ochakovski, G. A., Seitz, I. P., Wilhelm, B., Ueffing, M., Biel, M., Wissinger, B., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.08.018 · Cited by 145
“intravitreal injection on the outer nuclear layer showed that subretinal surgery was not inferior to intravitreal applicatio n.(12)”
Self-citationCellular mechanisms of hereditary photoreceptor degeneration – Focus on cGMP
Power, M., Das, S., Schütze, K., Marigo, V., Ekström, P. A. R., & Paquet‐Durand, F. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.005 · Cited by 128
Humoral immune response after intravitreal but not after subretinal AAV8 in primates and patients
Reichel, F. F., Peters, T., Wilhelm, B., Biel, M., Ueffing, M., Wissinger, B., Bartz-Schmidt, K. U., Klein, R., Michalakis, S., Fischer, M. D., et al. (2018) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22494 · Cited by 86
“Intravitreal may be considered the preferred route of administration when targeting inner layers or wide areas of the retina.(20) However, some authors have suggested that after intravitreal injections, neutralizing antibodies are more likely to be generated than after subretinal injections and that these antibodies h…”
BackgroundSelf-citationDevelopment of retinal atrophy after subretinal gene therapy with voretigene neparvovec
Reichel, F. F., Seitz, I. P., Wozar, F., Dimopoulos, S., Jung, R., Kempf, M., Kohl, S., Kortüm, F. C., Ott, S., Pohl, L., et al. (2022) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2021-321023 · Cited by 84
Self-citationOcular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
Ghoraba, H. H., Akhavanrezayat, A., Karaca, I., Yavari, N., Lajevardi, S., Hwang, J., Regenold, J., Matsumiya, W., Pham, B., Zaidi, M., et al. (2022) · Clinical Ophthalmology · doi:10.2147/opth.s364200 · Cited by 76
“Ochacovski et al(89) have shown that subretinal injection, in NHPs, can cause mild thinning of the outer layers of the fovea in comparison with an intravitreal injection of the same vector.(89,90) However, the difference was not clinically significant.”
ResultRetinal Cyclic Nucleotide-Gated Channels: From Pathophysiology to Therapy
Michalakis, S., Bećirović, E., & Biel, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030749 · Cited by 75
Self-citationDrug delivery to retinal photoreceptors
Himawan, E., Ekström, P. A. R., Buzgo, M., Gaillard, P. J., Stefánsson, E., Marigo, V., Loftsson, Þ., & Paquet‐Durand, F. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.004 · Cited by 68
The cGMP Pathway and Inherited Photoreceptor Degeneration: Targets, Compounds, and Biomarkers
Tolone, A., Belhadj, S., Rentsch, A., Schwede, F., & Paquet‐Durand, F. (2019) · Genes · doi:10.3390/genes10060453 · Cited by 51
“The procedure entails a detachment of the retina from the RPE with the risk for significant and irreversible retinal damage [87].”
BackgroundMethodInfluentialCHOROIDEREMIA: Retinal Degeneration With an Unmet Need
Pennesi, M. E., Birch, D. G., Duncan, J. L., Bennett, J., & Girach, A. (2019) · Retina · doi:10.1097/iae.0000000000002553 · Cited by 45
The influence of subretinal injection pressure on the microstructure of the monkey retina
Takahashi, K., Morizane, Y., Hisatomi, T., Tachibana, T., Kimura, S., Hosokawa, M. M., Shiode, Y., Hirano, M., Doi, S., Toshima, S., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209996 · Cited by 37
Restoring the oxidative balance in age-related diseases – An approach in glaucoma
Cáceres‐Vélez, P. R., Hui, F., Hercus, J., Bui, B. V., & Jusuf, P. R. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101572 · Cited by 38
“subretinal (Ochakovski et al., 2017), subtenon (Ohira et al.”
Salman, A., Kantor, A., McClements, M. E., Marfany, G., Trigueros, S., & MacLaren, R. E. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091842 · Cited by 37
Biomechanical considerations for optimising subretinal injections
L’Abbate, D., Prescott, K., Geraghty, B., Kearns, V., & STEEL, D. H. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.05.004 · Cited by 32
The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases
Davis, J. L. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.08.038 · Cited by 30
Novel AAV44.9-Based Vectors Display Exceptional Characteristics for Retinal Gene Therapy
Boye, S. L., Choudhury, S., Crosson, S., Di Pasquale, G., Afione, S., Mellen, R., Makal, V., Calabro, K. R., Fajardo, D., Peterson, J., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.04.002 · Cited by 29
Safety of same-eye subretinal sequential readministration of AAV2-hRPE65v2 in non-human primates
Weed, L., Ammar, M. J., Zhou, S., Wei, Z., Serrano, L. W., Sun, J., Lee, V., Maguire, A. M., Bennett, J., & Aleman, T. S. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.08.011 · Cited by 27
Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision
Karamali, F., Behtaj, S., Abraki, S. B., Hadady, H., Atefi, A., Savoj, S., Soroushzadeh, S., Najafian, S., Nasr‐Esfahani, M. H., & Klassen, H. J. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03738-4 · Cited by 27
“This method has been mostly used for retinal gene, and cell therapies [67, 68] and all the procedures should be carried out in one step, as repeated treatments could lead to retinal detachment [57, 58].”
MethodMorgan, J. I. W., Jiang, Y. Y., Vergilio, G. K., Serrano, L. W., Pearson, D. J., Bennett, J., Maguire, A. M., & Alemán, T. S. (2022) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2022.0158 · Cited by 25
Robot-assisted subretinal injection system: development and preliminary verification
Yang, K., Jin, X., Wang, Z., Fang, Y., Zhao, L., Yang, Z., Cong, J., Yang, Y., Huang, Y., & Wang, L. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02720-4 · Cited by 25
“The increasing popularity of subretinal injections with the rise of stem cell therapy and gene therapy is inextricably linked to the unique advantages of subretinal injections, which are mainly reflected in the ability of subretinal injections as a drug delivery method to act directly on the target area while reducing…”
BackgroundHints for gentle submacular injection in non-human primates based on intraoperative OCT guidance
Tan, G. S. W., Liu, Z., Ilmarinen, T., Barathi, V. A., Chee, C. K., Lingam, G., Su, X., & Stanzel, B. V. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.1.10 · Cited by 21
CRISPR delivery systems for organ-specific targeting: Advances and challenges
Du, J., Wu, Q., Liu, C., Wang, N., & Gong, C. (2025) · Precision medicine and engineering. · doi:10.1016/j.preme.2025.100048 · Cited by 21
PRPF31-retinitis pigmentosa: Challenges and opportunities for clinical translation
Aweidah, H., Xi, Z., Sahel, J., & Byrne, L. C. (2023) · Vision Research · doi:10.1016/j.visres.2023.108315 · Cited by 21
Hensman, J., Hahn, L. C., van Schooneveld, M. J., Diederen, R. M. H., ten Brink, J. B., Florijn, R. J., Bergen, A. A. B., Strubbe, I., Heutinck, P. A. T., van Genderen, M. M., et al. (2023) · Ophthalmology Retina · doi:10.1016/j.oret.2023.12.003 · Cited by 17
Song, Z., Xu, L., Wang, J., Rasti, R., Sastry, A., Li, J. D., Raynor, W., Izatt, J. A., Toth, C. A., Vajzovic, L. M., et al. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.07.020 · Cited by 11
“Loss W eighted − Dice soft = 1 − ∑ci C wci ∗ ∑bj BS Dice soft bj, ci BS , (4)”
Subretinal and Intravitreal Retinal Injections in Monkeys
Dauletbekov, D., Bartz‐Schmidt, K. U., & Fischer, M. D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7522-8_18 · Cited by 9
Self-citationSun, D., Sun, W., Gao, S., Lehrer, J., Wang, H., Hall, R. C. W., & Lu, Z. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03679-1 · Cited by 7
“Subretinal injection has the advantages of excellent transduction efficiency in the outer retinal cell layers and better targeting efficiency of specific retinal areas including macula [34–36].”
Maloca, P. M., Seeger, C., Booler, H. S., Valmaggia, P., Kawamoto, K., Kaba, Q., Inglin, N., Balaskas, K., Egan, C. A., Tufail, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99704-z · Cited by 7
Andrés‐Mateos, E., Kozlowski, C., Zhang, H., Fajardo, D., Xu, E. M., Navas‐Enamorado, I., Calabro, K. R., Rayaprolu, S., Havlik, L. P., Handy, T. E., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.014 · Cited by 4
Standard Operating Procedures for Common Laboratory Animal Ocular Procedures
Gilger, B. C., Bartoe, J. T., Eaton, J. S., & Boyd, R. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-78364-2_2 · Cited by 4
Subretinal Injection Volume Correlates to Persistent Outer Retinal Thinning in the Pig Eye
Seitz, I. P., Nyshchuk, R., Ellederová, Z., Ardan, T., Juhásová, J., Nemesh, Y., Juhás, Š., Drutovič, S., Süßkind, D., Schnichels, S., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.14.27 · Cited by 3
“35 Looking at higher volumes in NHPs, our own group has reported on foveal ONL thickness following subretinal sham injections of 200 μL.”
Self-citationWeed, L. (2019) · ScholarlyCommons (University of Pennsylvania)
Sakata, M., Araki, T., & Tomohiro, M. (2023) · Fundamental Toxicological Sciences · doi:10.2131/fts.10.199
Development of safe and efficient aav vectors for retinal gene therapy
Khabou, H. (2018) · theses.fr (ABES) · doi:10.70675/aa896663z9772z4d87z9bd1z247af1f0e3f1
Nyshchuk, R., Klein, J., Seitz, I. P., Peters, T. M., Mai, M., Ardan, T., Drutovič, S., Bohuslavová, B., Juhás, Š., Juhásová, J., et al. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111151
Self-citationOcular Safety and Efficacy of AAV-mediated Tyrosinase Gene Augmentation in a Nonhuman Primate ModelPreprint
Lim, J., Larimer-Picciani, A. M., Moshiri, A., Wang, J.-K., Takahashi, N., Raposo, A. C. S., Motta, M. J., Byrne, L. C., & Thomasy, S. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.13.738268
Calabro, K. R., Andrés‐Mateos, E., Kozlowski, C., Nemec, P. S., Xu, E. M., Crosson, S. M., Fajardo, D. S., Friend, H. L., Peterson, J. J., Li, W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.24.760972
Metadata
- Authors
- Ochakovski, G. A., Peters, T., Michalakis, S., Wilhelm, B., Wissinger, B., Biel, M., Bartz-Schmidt, K. U., Fischer, M. D., & for the RD-CURE Consortium
- Affiliations
- Universitätsklinikum Tübingen (DE)
- Center for Integrated Protein Science Munich (DE)
- University Eye Hospital, Centre for Ophthalmology, University Hospital Tübingen, Tübingen, Germany
- University of Oxford (GB)
- Corresponding author
- Fischer, M. Dominik
- ORCID
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2017-08-22
- Volume
- 58
- Issue
- 10
- Pages
- 4155
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2746908999
- Cited by
- 38
- References
- 29
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 8 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 2
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Korea University Business School
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- subretinal injection, intravitreal injection, ocular gene therapy, outer nuclear layer thinning, Macaca fascicularis, ellipsoid zone, non-inferiority
- MeSH terms
- Animals, Female, Fovea Centralis, Macaca fascicularis, Male, Retina, Visual Acuity, Genetic Therapy, Photoreceptor Cells, Vertebrate, Tomography, Optical Coherence, Retinal Pigment Epithelium, Injections, Intraocular, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.